Meridian Bioscience Reports Fourth Quarter and Full-Year Fiscal 2019 Operating Results and Provides Fiscal 2020 Guidance
CINCINNATI, Nov. 07, 2019 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2019. Fourth Quarter 2019 Highlights (Comparison to Fourth Quarter Fiscal 2018): Consolidated revenue decreased 4% to $50.8 million (3% decrease in constant-currency) Diagnostics segment revenues decreased 9% to $33.4 […]